Hospital
Jackson Hma LLC
Jackson Hma LLC was paid $30.94M by Medicaid between Jan 2018 and Dec 2024, across 270 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoJACKSON HMA LLC
JACKSON, MS 39204
JACKSON, MS 39204
33aNPI1033163092assigned 05/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$30.94M
24GClaims829,165
24DCodes billed270
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#17 of 77
Median peer was paid$8.23M
This provider vs. median3.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 145,198 | $5.89M | |
| 2019 | 135,487 | $5.48M | |
| 2020 | 111,113 | $3.74M | |
| 2021 | 131,619 | $4.54M | |
| 2022 | 143,202 | $4.47M | |
| 2023 | 101,446 | $3.89M | |
| 2024incomplete | 61,100 | $2.94M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 59,478 | 46,145 | $7.65M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 24,371 | 18,566 | $4.09M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.2% | 19,092 | 15,902 | $1.61M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.8% | 5,670 | 4,366 | $1.19M |
| G0378 | Hospital observation service, per hour | 3.6% | 4,565 | 2,298 | $1.12M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.6% | 13,459 | 9,976 | $1.11M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 24,120 | 17,355 | $885K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.7% | 17,460 | 14,698 | $840K |
| 87428 | 2.0% | 11,925 | 9,821 | $614K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.7% | 14,436 | 3,707 | $530K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 3,110 | 2,462 | $511K |
| 71045 | Radiologic examination, chest; single view | 1.6% | 13,668 | 10,224 | $506K |
258 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.6% | 4,980 | $493K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 10,905 | $419K |
| 15002 | 1.3% | 630 | $396K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 16,733 | $344K |
| 93458 | 1.1% | 371 | $336K | |
| 86900 | 1.0% | 5,604 | $317K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,640 | $283K |
| 86886 | <1% | 3,760 | $266K | |
| 75625 | <1% | 312 | $261K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,970 | $260K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 2,609 | $254K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 8,063 | $251K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 15,804 | $247K |
| 11043 | <1% | 1,550 | $228K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,356 | $219K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 3,508 | $213K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,715 | $207K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,351 | $204K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 36,861 | $189K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,358 | $188K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,932 | $186K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,303 | $171K |
| 80053 | Comprehensive metabolic panel | <1% | 22,893 | $155K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 389 | $152K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 4,519 | $148K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 11,264 | $136K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,115 | $132K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,611 | $129K |
| 11044 | <1% | 325 | $119K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 6,076 | $106K |
| 15273 | <1% | 89 | $101K | |
| 86901 | <1% | 5,594 | $97K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,296 | $93K |
| 75716 | <1% | 131 | $84K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 14,222 | $83K |
| 73130 | <1% | 1,955 | $83K | |
| 84703 | <1% | 14,627 | $83K | |
| 72100 | <1% | 1,536 | $79K | |
| 73562 | <1% | 1,916 | $78K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 36,549 | $73K |
| 73630 | <1% | 1,870 | $73K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12,161 | $72K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 211 | $70K |
| 15004 | <1% | 469 | $70K | |
| 74018 | <1% | 1,590 | $68K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,016 | $67K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 894 | $66K |
| 81001 | <1% | 28,589 | $64K | |
| 73030 | <1% | 1,690 | $63K | |
| 97165 | <1% | 1,761 | $62K | |
| 84484 | <1% | 8,751 | $61K | |
| 37229 | <1% | 14 | $61K | |
| 76801 | <1% | 834 | $58K | |
| 83880 | <1% | 2,801 | $56K | |
| 73610 | <1% | 1,339 | $55K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,477 | $55K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,376 | $53K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 690 | $53K |
| 97760 | <1% | 1,801 | $51K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 6,716 | $44K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 878 | $43K |
| 87081 | <1% | 7,355 | $40K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,675 | $39K |
| 10060 | <1% | 408 | $38K | |
| 97162 | <1% | 1,030 | $35K | |
| 87186 | <1% | 4,563 | $33K | |
| 84702 | <1% | 2,938 | $32K | |
| 83690 | <1% | 6,905 | $32K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 302 | $32K |
| 93976 | <1% | 473 | $31K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,628 | $31K |
| 87077 | <1% | 4,463 | $30K | |
| 80061 | Lipid panel | <1% | 2,768 | $27K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,582 | $27K |
| 97116 | <1% | 1,976 | $27K | |
| 59025 | Fetal non-stress test | <1% | 240 | $26K |
| 72040 | <1% | 711 | $24K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 537 | $24K |
| 85730 | <1% | 5,957 | $22K | |
| 93017 | <1% | 337 | $22K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 564 | $21K |
| 87807 | <1% | 1,932 | $20K | |
| 15277 | <1% | 33 | $19K | |
| 73110 | <1% | 479 | $18K | |
| 85610 | <1% | 7,179 | $18K | |
| 93971 | <1% | 474 | $18K | |
| 82962 | <1% | 8,995 | $16K | |
| 81025 | <1% | 2,604 | $15K | |
| 87040 | <1% | 1,731 | $14K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 374 | $13K |
| D1120 | Dental cleaning, child | <1% | 617 | $13K |
| 82077 | <1% | 1,358 | $13K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 429 | $12K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 298 | $12K |
| 76830 | Ultrasound, transvaginal | <1% | 167 | $12K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 378 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 433 | $10K |
| 97161 | <1% | 286 | $10K | |
| 97010 | <1% | 3,521 | $10K | |
| 87070 | <1% | 1,529 | $10K | |
| 83605 | <1% | 1,698 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,472 | $10K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 58 | $9K |
| 94010 | <1% | 284 | $9K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 128 | $8K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 848 | $8K |
| 94726 | <1% | 146 | $8K | |
| 85027 | <1% | 1,873 | $8K | |
| 93979 | <1% | 192 | $7K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,828 | $7K |
| 87210 | <1% | 1,884 | $7K | |
| 75710 | <1% | 18 | $7K | |
| 83735 | <1% | 2,316 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 477 | $7K |
| 12001 | <1% | 65 | $6K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 32 | $6K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 80 | $6K |
| 86850 | <1% | 224 | $6K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 106 | $6K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 53 | $6K |
| 17999 | <1% | 77 | $6K | |
| 93970 | <1% | 93 | $6K | |
| 73590 | <1% | 128 | $6K | |
| 73140 | <1% | 144 | $5K | |
| 84439 | <1% | 873 | $5K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 551 | $5K |
| 73502 | <1% | 172 | $5K | |
| Q4116 | Alloderm, per square centimeter (add-on, list separately in addition to primary procedure) | <1% | 179 | $5K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 101 | $5K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 7,688 | $5K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 47 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 182 | $4K |
| 36830 | <1% | 12 | $4K | |
| 73560 | <1% | 88 | $4K | |
| 85652 | <1% | 851 | $4K | |
| 86780 | <1% | 461 | $4K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 48 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 49 | $4K |
| 86140 | <1% | 1,113 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 11,457 | $4K |
| 93978 | <1% | 37 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 8,370 | $3K |
| 12011 | <1% | 25 | $3K | |
| 81003 | <1% | 2,733 | $3K | |
| 82550 | <1% | 676 | $3K | |
| 85379 | <1% | 467 | $3K | |
| 16020 | <1% | 45 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16,370 | $3K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 1,739 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 5,003 | $2K |
| 93925 | <1% | 72 | $2K | |
| 97163 | <1% | 53 | $2K | |
| 72131 | <1% | 54 | $2K | |
| J3246 | Injection, tirofiban hcl, 0.25 mg | <1% | 141 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 5,685 | $2K |
| 76642 | <1% | 49 | $2K | |
| 82565 | <1% | 495 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,468 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 63 | $1K |
| 12002 | <1% | 14 | $1K | |
| 76818 | <1% | 16 | $1K | |
| 84550 | <1% | 394 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 44 | $1K |
| C1769 | Guide wire | <1% | 2,266 | $1K |
| C1760 | Closure device, vascular (implantable/insertable) | <1% | 1,406 | $1K |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | <1% | 1,152 | $1K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,567 | $983.26 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 15 | $839.41 |
| 80074 | <1% | 74 | $838.50 | |
| 73620 | <1% | 17 | $829.14 | |
| 96376 | <1% | 2,540 | $756.72 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 7,541 | $720.78 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 1,610 | $710.86 |
| 70486 | <1% | 13 | $686.76 | |
| 97166 | <1% | 18 | $645.50 | |
| 99152 | <1% | 2,829 | $607.54 | |
| 87340 | <1% | 87 | $581.10 | |
| 82803 | <1% | 33 | $561.19 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 193 | $550.35 |
| 73090 | <1% | 14 | $533.51 | |
| 87806 | <1% | 32 | $530.82 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 9,201 | $521.95 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,666 | $499.55 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 3,030 | $471.36 |
| 73080 | <1% | 23 | $430.21 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 8,299 | $413.39 |
| 80076 | <1% | 51 | $382.34 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 322 | $365.10 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 8,153 | $345.60 |
| 87641 | <1% | 20 | $312.78 | |
| J2704 | Injection, propofol, 10 mg | <1% | 5,712 | $239.26 |
| 15005 | <1% | 20 | $226.90 | |
| 97014 | <1% | 25 | $205.61 | |
| 84100 | <1% | 133 | $197.18 | |
| 85384 | <1% | 30 | $194.99 | |
| 0479T | <1% | 126 | $191.98 | |
| 0480T | <1% | 77 | $191.98 | |
| 81000 | <1% | 74 | $187.11 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,454 | $185.82 |
| 81005 | <1% | 132 | $166.72 | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 26 | $147.64 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 128 | $139.94 |
| 84525 | <1% | 30 | $129.76 | |
| 15003 | <1% | 172 | $127.75 | |
| 82607 | <1% | 18 | $122.41 | |
| 85362 | <1% | 26 | $111.74 | |
| 81002 | <1% | 33 | $76.06 | |
| D0350 | <1% | 13 | $73.58 | |
| 82570 | <1% | 22 | $69.87 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,083 | $68.43 |
| 84156 | <1% | 23 | $56.07 | |
| 15278 | <1% | 16 | $44.81 | |
| 90714 | <1% | 786 | $44.52 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 1,320 | $43.71 |
| 90715 | <1% | 344 | $22.50 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,650 | $21.42 |
| 99153 | Mod sedat endo service >5yrs | <1% | 1,846 | $20.18 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 314 | $17.15 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 2,756 | $15.28 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,096 | $5.71 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 246 | $5.22 |
| G1002 | Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program | 0% | 160 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 1,200 | $0.00 |
| 15274 | 0% | 73 | $0.00 | |
| J0595 | Injection, butorphanol tartrate, 1 mg | 0% | 95 | $0.00 |
| 94729 | 0% | 147 | $0.00 | |
| C1762 | Connective tissue, human (includes fascia lata) | 0% | 112 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 72 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 17 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 171 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 513 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 217 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 12 | $0.00 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 0% | 60 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 49 | $0.00 |
| 76937 | 0% | 17 | $0.00 | |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 24 | $0.00 |
| C1724 | Catheter, transluminal atherectomy, rotational | 0% | 15 | $0.00 |
| 99157 | 0% | 14 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 163 | $0.00 |
| 94760 | 0% | 1,039 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 342 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 705 | $0.00 |
| 99156 | 0% | 14 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 345 | $0.00 |
| Q4100 | Skin substitute, not otherwise specified | 0% | 629 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 32 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 171 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 143 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 157 | $0.00 |
| C1768 | Graft, vascular | 0% | 14 | $0.00 |
| J3490 | Unclassified drugs | 0% | 144 | $0.00 |
| 11045 | 0% | 14 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 227 | $0.00 |
| 77001 | 0% | 17 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 35 | $0.00 |
| D0140 | Limited oral evaluation - problem focused | 0% | 48 | $0.00 |
| D4355 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.